Published in Health Business Week, November 12th, 2004
In a recent study, F. Gonzalez-Martinez and colleagues at the Institute of Nephrology and Urology in Montevideo "analyzed changes in different lymphocyte subpopulations after anti-CD3 treatment."
"T lymphocytes were decreased under anti-CD3 antibody administration, with a simultaneous increase in B lymphocytes but no changes in natural killer (NK) cells," test results showed. "No differences were found between patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.